Tin-based Antitumour Drugs
1994
Tin-Based Antitumour Drugs
publication
Evidence: moderate
Author Information
Author(s): Marcel Gielen
Primary Institution: Free University of Brussels V.U.B.
Hypothesis
The study investigates the antitumour activity of various tin-based compounds compared to cisplatin.
Conclusion
Several organotin compounds exhibit promising in vitro antitumour activities against human tumour cell lines.
Supporting Evidence
- The dimethyltin compound was found inactive in vitro, while other diorganotin compounds showed higher activity than cisplatin.
- Some di-n-butyltin derivatives exhibited better activity against human tumour cell lines than doxorubicin.
- Triphenyltin carboxylates were found to be as active in vitro as mitomycin C.
Takeaway
Scientists are testing new tin-based medicines to see if they can help fight cancer better than current treatments.
Methodology
The study involved synthesizing and testing various diorganotin compounds against human tumour cell lines to evaluate their antitumour activity.
Limitations
The study only reports in vitro results, and further in vivo testing is needed to confirm the effectiveness of the compounds.
Want to read the original?
Access the complete publication on the publisher's website